These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 2777959)

  • 1. Identification of some human urinary metabolites of the intoxicating beverage kava.
    Duffield AM; Jamieson DD; Lidgard RO; Duffield PH; Bourne DJ
    J Chromatogr; 1989 Jul; 475():273-81. PubMed ID: 2777959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LC-UV and LC-MS analysis of food and drink products containing kava.
    de Jager LS; Perfetti GA; Diachenko GW
    Food Addit Contam; 2004 Oct; 21(10):921-34. PubMed ID: 15712517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, in vitro, reactivity, and identification of 6-phenyl-3-hexen-2-one in human urine after kava-kava (Piper methysticum) ingestion.
    Zou L; Harkey MR; Henderson GL
    Planta Med; 2005 Feb; 71(2):142-6. PubMed ID: 15729622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification by methane chemical ionization gas chromatography/mass spectrometry of the products obtained by steam distillation and aqueous acid extraction of commercial Piper methysticum.
    Cheng D; Lidgard RO; Duffield PH; Duffield AM; Brophy JJ
    Biomed Environ Mass Spectrom; 1988 Nov; 17(5):371-6. PubMed ID: 3207926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A UHPLC-UV Method Development and Validation for Determining Kavalactones and Flavokavains in
    Tang Y; Fields C
    Molecules; 2019 Mar; 24(7):. PubMed ID: 30934989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uptake into mouse brain of four compounds present in the psychoactive beverage kava.
    Keledjian J; Duffield PH; Jamieson DD; Lidgard RO; Duffield AM
    J Pharm Sci; 1988 Dec; 77(12):1003-6. PubMed ID: 3244102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-Lab Validation for Determination of Kavalactones and Flavokavains in Piper methysticum (Kava).
    Liu Y; Lund JA; Murch SJ; Brown PN
    Planta Med; 2018 Nov; 84(16):1213-1218. PubMed ID: 29940660
    [No Abstract]   [Full Text] [Related]  

  • 8. Characterization of Different Forms of Kava (Piper methysticum) Products by UPLC-MS/MS.
    Mamallapalli J; Kanumuri SRR; Corral P; Johnston E; Zhuang C; McCurdy CR; Mathews CA; Sharma A; Xing C
    Planta Med; 2022 Nov; 88(14):1348-1359. PubMed ID: 34839465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical archaeology of kava, a potent brew.
    Hocart CH; Fankhauser B; Buckle DW
    Rapid Commun Mass Spectrom; 1993 Mar; 7(3):219-24. PubMed ID: 8481541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and Purification of Potent Growth Inhibitors from
    Van TM; Xuan TD; Minh TN; Quan NV
    Molecules; 2018 Jul; 23(8):. PubMed ID: 30065174
    [No Abstract]   [Full Text] [Related]  

  • 11. Analysis of kavalactones from Piper methysticum (kava-kava).
    Bilia AR; Scalise L; Bergonzi MC; Vincieri FF
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Dec; 812(1-2):203-14. PubMed ID: 15556499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of cytochrome P450 3A4 by extracts and kavalactones of Piper methysticum (Kava-Kava).
    Unger M; Holzgrabe U; Jacobsen W; Cummins C; Benet LZ
    Planta Med; 2002 Dec; 68(12):1055-8. PubMed ID: 12494328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Composition and biological activity of traditional and commercial kava extracts.
    Côté CS; Kor C; Cohen J; Auclair K
    Biochem Biophys Res Commun; 2004 Sep; 322(1):147-52. PubMed ID: 15313185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug absorption in vitro model: filter-immobilized artificial membranes. 2. Studies of the permeability properties of lactones in Piper methysticum Forst.
    Avdeef A; Strafford M; Block E; Balogh MP; Chambliss W; Khan I
    Eur J Pharm Sci; 2001 Dec; 14(4):271-80. PubMed ID: 11684401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Herbicidal and Fungicidal Activities of Lactones in Kava (Piper methysticum).
    Xuan TD; Elzaawely AA; Fukuta M; Tawata S
    J Agric Food Chem; 2006 Feb; 54(3):720-5. PubMed ID: 16448174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical pharmacokinetics of kavalactones after oral dosing of standardized kava extract in healthy volunteers.
    Kanumuri SRR; Mamallapalli J; Nelson R; McCurdy CR; Mathews CA; Xing C; Sharma A
    J Ethnopharmacol; 2022 Oct; 297():115514. PubMed ID: 35777607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of kava lactones in food supplements by liquid chromatography-atmospheric pressure chemical ionisation tandem mass spectrometry.
    Bobeldijk I; Boonzaaijer G; Spies-Faber EJ; Vaes WH
    J Chromatogr A; 2005 Mar; 1067(1-2):107-14. PubMed ID: 15844515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of novel electrophilic metabolites of piper methysticum Forst (Kava).
    Johnson BM; Qiu SX; Zhang S; Zhang F; Burdette JE; Yu L; Bolton JL; van Breemen RB
    Chem Res Toxicol; 2003 Jun; 16(6):733-40. PubMed ID: 12807356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of commercial kava extracts and kavalactone standards for mutagenicity and toxicity using the mammalian cell gene mutation assay in L5178Y mouse lymphoma cells.
    Whittaker P; Clarke JJ; San RH; Betz JM; Seifried HE; de Jager LS; Dunkel VC
    Food Chem Toxicol; 2008 Jan; 46(1):168-74. PubMed ID: 17822821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigating volatiles as the secondary metabolome of Piper methysticum from root powder and water extracts using comprehensive two-dimensional gas chromatography.
    Cheung C; Baker JD; Byrne JM; Perrault KA
    J Ethnopharmacol; 2022 Aug; 294():115346. PubMed ID: 35533912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.